ISOTECHNIKA INC. CONSOLIDATED BALANCE SHEET  
As at February 28,1999
(Unaudited)
 
 
1999
1998
ASSETS
 
Current
Cash and short term investments
$ 1,766,515
$ -
Accounts Receivable
387,466
167,681
Inventories
319,377
95,227
Prepaid expenses and deferred costs
18,308
13,927

  2,491,666
276,835
 
Capital assets, net
791,647
1,369,744
Patent costs
647,058
449,428
Deferred start-up costs
-
62,983

 
$ 3,930,371
$2,158,990



LIABILITIES
 
Current
Bank indebtedness
$ -
$ 192,129
Bank demand loans
630,000
-
Accounts payable and accrued liabilities
1,532,097
1,187,352
Promissory Note
292,000
-
Current portion of obligations under capital leases
41,305
160,907
Current portion of long-term debt
-
56,785

  2,495,402
1,597,173
 
Obligations under capital leases
51,653
92,958
Long-term debt
75,000
122,433

 
2,622,055
1,812,564

 
Shareholders' Equity
Share capital Issued 26,778,376 shares (1997 - 23,083,200)
9,625,998
5,773,168
Deficit
(8,317,682)
(5,426,742)

  1,308,316
346,426

  $ 3,930,371
$ 2,158,990



ISOTECHNIKA INC. CONSOLIDATED STATEMENT OF OPERATIONS AND DEFICIT  
For the three months ended February 28, 1999
(Unaudited)
 
 
1999
1998
Revenue
Product sales and contract analysis
$ 617,019
$ 338,877
Licensing, royalties and other
157,661
74,574
Interest
26,595
3,123

  801,275
416,574

 
Expenses
Research and development
372,933
564,577
Selling and administration
356,572
347,448
Cost of product sales and contract analysis
357,049
159,449
Depreciation & amortization
72,855
99,273
Interest on long-term debt
1,956
4,920

 
1,161,365
1,175,667

 
(360,090)
(759,093)
 
Other Income
Research and development tax credits
417,844
-

 
Net loss for the period
57,754
(759,093)
Deficit, beginning of period
(8,375,434)
(4,667,649)

 

Deficit, end of period
$ (8,317,680)
$ (5,426,742)



Loss per share
$ 0.002
$ (0.03)



ISOTECHNIKA INC. CONSOLIDATED STATEMENT OF CHANGES IN FINANCIAL POSITION  
For the three months ended February 28, 1999
(Unaudited)
 
 
1999
1998
Operating activities
 
Net loss for the period
$ 57,754
$ (759,093)
Item not affecting cash Depreciation & amortization
72,855
99,273
Net changes in non-cash compnents of working capital
(69,176)
319,111

  61,433
(340,709)
 
Investing activities
 
Purchase of capital assets
(4,497)
(112,402)
Scientific research and development tax credit related to capital assets
28,499
-
Patent costs
(7,828)
(15,363)

  16,174
(127,765)
 
Financing activities
 
Bank demand loans
630,000
-
Repayment of promissory notes and loans payable
(1,250,000)
-
Obligations under capital leases
-
112,400
Repayment of capital leases
(24,217)
(53,150)
Repayment of long-term debt
-
(13,629)
Issuance of share capital, net of share issue costs
2,556,144
-

  1,911,927
45,621

 
Increase (decrease) in cash
1,989,534
(422,853)
 
Cash position, beginning of period
(223,019)
230,724

Cash position, end of period
$1,766,515
$(192,129)



Approved on behalf of the Board
Doug Walker, Director      Joseph Koziak, Director